DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,200 filers reported holding DANAHER CORPORATION in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $302,000 | +28.0% | 2,290 | 0.0% | 0.04% | +27.6% |
Q4 2018 | $236,000 | -21.1% | 2,290 | -16.7% | 0.03% | -6.5% |
Q3 2018 | $299,000 | +9.9% | 2,750 | 0.0% | 0.03% | 0.0% |
Q2 2018 | $272,000 | -0.4% | 2,750 | -1.3% | 0.03% | 0.0% |
Q1 2018 | $273,000 | +7.1% | 2,785 | +1.3% | 0.03% | +14.8% |
Q4 2017 | $255,000 | +8.1% | 2,750 | 0.0% | 0.03% | +8.0% |
Q3 2017 | $236,000 | +1.7% | 2,750 | 0.0% | 0.02% | 0.0% |
Q2 2017 | $232,000 | -1.7% | 2,750 | 0.0% | 0.02% | -7.4% |
Q1 2017 | $236,000 | +10.3% | 2,750 | 0.0% | 0.03% | +17.4% |
Q4 2016 | $214,000 | -0.5% | 2,750 | 0.0% | 0.02% | 0.0% |
Q3 2016 | $215,000 | -22.7% | 2,750 | 0.0% | 0.02% | -25.8% |
Q2 2016 | $278,000 | +6.5% | 2,750 | 0.0% | 0.03% | +6.9% |
Q1 2016 | $261,000 | -0.8% | 2,750 | -2.8% | 0.03% | -6.5% |
Q4 2015 | $263,000 | +1.9% | 2,830 | -6.6% | 0.03% | 0.0% |
Q3 2015 | $258,000 | -6.9% | 3,030 | -6.2% | 0.03% | -8.8% |
Q2 2015 | $277,000 | -2.8% | 3,230 | -3.6% | 0.03% | -2.9% |
Q1 2015 | $285,000 | -15.9% | 3,350 | -15.2% | 0.04% | -12.5% |
Q4 2014 | $339,000 | -55.6% | 3,950 | -60.0% | 0.04% | -14.9% |
Q3 2014 | $763,000 | +94.1% | 9,864 | +97.6% | 0.05% | -4.1% |
Q2 2014 | $393,000 | +11.3% | 4,993 | +5.9% | 0.05% | 0.0% |
Q1 2014 | $353,000 | -5.4% | 4,715 | -2.5% | 0.05% | -5.8% |
Q4 2013 | $373,000 | +7.8% | 4,837 | -3.3% | 0.05% | 0.0% |
Q3 2013 | $346,000 | -11.3% | 5,000 | -18.7% | 0.05% | -14.8% |
Q2 2013 | $390,000 | – | 6,150 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |